These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 36537806)

  • 21. Trehalose-Induced Remodelling of the Human Microbiota Affects
    Buckley AM; Moura IB; Arai N; Spittal W; Clark E; Nishida Y; Harris HC; Bentley K; Davis G; Wang D; Mitra S; Higashiyama T; Wilcox MH
    Front Cell Infect Microbiol; 2021; 11():670935. PubMed ID: 34277467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring novel microbial metabolites and drugs for inhibiting
    Abouelkhair AA; Seleem MN
    mSphere; 2024 Jul; 9(7):e0027324. PubMed ID: 38940508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2'-Fucosyllactose inhibits proliferation of
    Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
    Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frontiers in antibiotic alternatives for
    Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
    World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlating Antibiotic-Induced Dysbiosis to
    Moore JH; Salahi A; Honrado C; Warburton C; Tate S; Warren CA; Swami NS
    ACS Infect Dis; 2023 Oct; 9(10):1878-1888. PubMed ID: 37756389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
    Phan JR; Do DM; Truong MC; Ngo C; Phan JH; Sharma SK; Schilke A; Mefferd CC; Villarama JV; Lai D; Consul A; Hedlund BP; Firestine SM; Abel-Santos E
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0143521. PubMed ID: 34780262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During
    Costa DVS; Moura-Neto V; Bolick DT; Guerrant RL; Fawad JA; Shin JH; Medeiros PHQS; Ledwaba SE; Kolling GL; Martins CS; Venkataraman V; Warren CA; Brito GAC
    Front Cell Infect Microbiol; 2021; 11():739874. PubMed ID: 34568098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
    Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
    Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-virulence strategies for
    Stewart D; Anwar F; Vedantam G
    Gut Microbes; 2020 Nov; 12(1):1802865. PubMed ID: 33092487
    [No Abstract]   [Full Text] [Related]  

  • 30. Emerging alternatives against Clostridioides difficile infection.
    Romero-Rodríguez A; Martínez de la Peña C; Troncoso-Cotal S; Guzmán C; Sánchez S
    Anaerobe; 2022 Dec; 78():102638. PubMed ID: 36210608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
    Abutaleb NS; Seleem MN
    Sci Rep; 2020 May; 10(1):7701. PubMed ID: 32382070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An insight into
    Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
    Yang J; Meng L; Yang H
    Microbiol Spectr; 2022 Apr; 10(2):e0067222. PubMed ID: 35311540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Chicken IgY Specific to
    Pizarro-Guajardo M; Díaz-González F; Álvarez-Lobos M; Paredes-Sabja D
    Front Cell Infect Microbiol; 2017; 7():365. PubMed ID: 28856119
    [No Abstract]   [Full Text] [Related]  

  • 38. Spore-Forming
    Chisholm JM; Putsathit P; Riley TV; Lim SC
    Microbiol Spectr; 2023 Feb; 11(1):e0358222. PubMed ID: 36475924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ridinilazole: a novel therapy for Clostridium difficile infection.
    Vickers RJ; Tillotson G; Goldstein EJ; Citron DM; Garey KW; Wilcox MH
    Int J Antimicrob Agents; 2016 Aug; 48(2):137-43. PubMed ID: 27283730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridioides difficile infection in Africa: A narrative review.
    Kullin B; Abratt VR; Reid SJ; Riley TV
    Anaerobe; 2022 Apr; 74():102549. PubMed ID: 35337974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.